Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
6.13
-0.09 (-1.45%)
Jun 11, 2026, 3:04 PM CST
SHE:002412 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 160.91 | 249.65 | 128.02 | 51.13 | 145.41 | 90.31 |
Trading Asset Securities | 410.02 | 333.8 | 244.12 | 203.87 | 135.82 | 49.24 |
Cash & Short-Term Investments | 570.93 | 583.45 | 372.14 | 255 | 281.23 | 139.55 |
Cash Growth | 36.60% | 56.78% | 45.94% | -9.33% | 101.52% | 34.75% |
Accounts Receivable | 399.04 | 426.42 | 425.03 | 352.52 | 320.57 | 272.88 |
Other Receivables | 102.48 | 0.94 | 0.88 | 0.63 | 11.96 | 1.86 |
Receivables | 501.52 | 437.17 | 442 | 359.99 | 332.53 | 274.74 |
Inventory | 215.02 | 208.44 | 222.88 | 231.12 | 246.62 | 103.37 |
Prepaid Expenses | - | 9.13 | 6.9 | 3.8 | - | 1.23 |
Other Current Assets | 90.32 | 83.62 | 79.25 | 46.16 | 5.03 | 16.51 |
Total Current Assets | 1,378 | 1,322 | 1,123 | 896.07 | 865.4 | 535.41 |
Property, Plant & Equipment | 449.26 | 455.72 | 489.16 | 515.61 | 439.45 | 470.75 |
Long-Term Investments | 827.98 | 836.44 | 855.75 | 841.81 | 781.35 | 707.95 |
Goodwill | 14.73 | 14.73 | 14.79 | 14.79 | 14.79 | 53.03 |
Other Intangible Assets | 28.76 | 28.66 | 29.3 | 29.54 | 33.72 | 42.58 |
Long-Term Deferred Tax Assets | 2.12 | 2.24 | 2.42 | 2.5 | 2.04 | 2.11 |
Long-Term Deferred Charges | 14.73 | 14.94 | 14.41 | 15.13 | 15.71 | 16.42 |
Other Long-Term Assets | 18.06 | 18.52 | 18.23 | 21.04 | 138.47 | 283.03 |
Total Assets | 2,733 | 2,693 | 2,547 | 2,336 | 2,291 | 2,111 |
Accounts Payable | 33.91 | 34.28 | 41.62 | 41.11 | 43.63 | 51.44 |
Accrued Expenses | 17.4 | 49.97 | 48.31 | 62.58 | 66.83 | 48.31 |
Short-Term Debt | 50.98 | 57.5 | 84.51 | 95.12 | 120.15 | 131.79 |
Current Income Taxes Payable | 14.01 | 9.04 | 6.23 | 11.64 | 4.61 | 4.52 |
Current Unearned Revenue | 1.83 | 0.81 | 2.72 | 6.48 | 7.02 | 1.71 |
Other Current Liabilities | 169.05 | 136.72 | 134.93 | 138.51 | 138 | 113.33 |
Total Current Liabilities | 287.17 | 288.33 | 318.32 | 355.42 | 380.24 | 351.11 |
Long-Term Unearned Revenue | 22.49 | 23.01 | 24.54 | 16.81 | 15.03 | 16.22 |
Long-Term Deferred Tax Liabilities | 0.83 | 0.81 | 1 | 1.22 | 1.54 | 1.66 |
Total Liabilities | 310.49 | 312.15 | 343.85 | 373.46 | 396.81 | 368.99 |
Common Stock | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 |
Additional Paid-In Capital | 234.12 | 234.12 | 234.12 | 234.12 | 234.12 | 232.77 |
Retained Earnings | 1,672 | 1,634 | 1,436 | 1,215 | 1,161 | 993.7 |
Comprehensive Income & Other | 13.47 | 9.87 | 30.45 | 10.34 | -4.5 | 12.63 |
Total Common Equity | 2,423 | 2,381 | 2,203 | 1,963 | 1,894 | 1,742 |
Shareholders' Equity | 2,423 | 2,381 | 2,203 | 1,963 | 1,894 | 1,742 |
Total Liabilities & Equity | 2,733 | 2,693 | 2,547 | 2,336 | 2,291 | 2,111 |
Total Debt | 50.98 | 57.5 | 84.51 | 95.12 | 120.15 | 131.79 |
Net Cash (Debt) | 519.95 | 525.95 | 287.63 | 159.88 | 161.08 | 7.76 |
Net Cash Growth | 55.29% | 82.86% | 79.90% | -0.74% | 1975.89% | - |
Net Cash Per Share | 1.03 | 1.05 | 0.57 | 0.32 | 0.32 | 0.02 |
Filing Date Shares Outstanding | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 |
Total Common Shares Outstanding | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 | 503.2 |
Working Capital | 1,091 | 1,033 | 804.85 | 540.65 | 485.17 | 184.3 |
Book Value Per Share | 4.82 | 4.73 | 4.38 | 3.90 | 3.76 | 3.46 |
Tangible Book Value | 2,379 | 2,338 | 2,159 | 1,919 | 1,846 | 1,647 |
Tangible Book Value Per Share | 4.73 | 4.65 | 4.29 | 3.81 | 3.67 | 3.27 |
Buildings | - | 648.15 | 647.47 | 644.48 | 531.89 | 533.67 |
Machinery | - | 231.59 | 228.7 | 223.66 | 221.69 | 218.69 |
Construction In Progress | - | 12.77 | 10.8 | 9.08 | 6.09 | 5.26 |